Literature DB >> 27744272

Development and Validity of Western University's On-Road Assessment.

Sherrilene Classen1, Sarah Krasniuk1, Liliana Alvarez1, Miriam Monahan1, Sarah A Morrow1,2, Tim Danter3.   

Abstract

Although used across North America, many on-road studies do not explicitly document the content and metrics of on-road courses and accompanying assessments. This article discusses the development of the University of Western Ontario's on-road course, and elucidates the validity of its accompanying on-road assessment. We identified main components for developing an on-road course and used measurement theory to establish face, content, and initial construct validity. Five adult volunteer drivers and 30 drivers with multiple sclerosis participated in the study. The road course had face and content validity, representing 100% of roadway components determined through a content validity matrix and index. The known-groups method showed that debilitated drivers (vs. not debilitated), made more driving errors ( W = 463.50, p = .03), and failed the on-road course, indicating preliminary construct validity of the on-road assessment. This research guides and empirically supports a process for developing a road course and its assessment.

Entities:  

Keywords:  assessment; driving; psychometrics; road course development

Mesh:

Year:  2016        PMID: 27744272     DOI: 10.1177/1539449216672859

Source DB:  PubMed          Journal:  OTJR (Thorofare N J)        ISSN: 1539-4492


  2 in total

1.  Standardized on-road tests assessing fitness-to-drive in people with cognitive impairments: A systematic review.

Authors:  David Bellagamba; Line Vionnet; Isabel Margot-Cattin; Paul Vaucher
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

2.  RCT protocol for driving performance in people with Parkinson's using autonomous in-vehicle technologies.

Authors:  Sherrilene Classen; Yuan Li; Wayne Giang; Sandra Winter; Jiajun Wei; Bhavana Patel; Mary Jeghers; Beth Gibson; Jason Rogers; Adolfo Ramirez-Zamora
Journal:  Contemp Clin Trials Commun       Date:  2022-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.